PMA device
Kamra Inlay
Corneagen · Implant, Corneal, Refractive (LQE, Class III) · First FDA decision May 12, 2016, newest Jul 18, 2017Keratoconus and corneal diseaseNearsightedness and refractive error
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
6
Naming "Kamra Inlay"
MAUDE reports
9
Brand "Kamra Inlay", since 2015
PubMed studies
29
Mentioning "Kamra Inlay"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Kamra Inlay
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- KAMRA INLAYPMA supplement
P120023-S005 · Decided Jul 18, 2017 · 174 days after receipt · Normal 180 Day Track No User Fee
Device type: Implant, corneal, refractive (LQE) · Ophthalmology
- KAMRA INLAYPMA supplement
P120023-S004 · Decided May 16, 2017 · 230 days after receipt · Normal 180 Day Track No User Fee
Device type: Implant, corneal, refractive (LQE) · Ophthalmology
- KAMRA INLAYPMA supplement
P120023-S002 · Decided Oct 7, 2016 · 345 days after receipt · Normal 180 Day Track
Device type: Implant, corneal, refractive (LQE) · Ophthalmology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Kamra Inlay", any status and sponsor, newest update first.
AcuFocus, Inc.Not on our public-company list
NCT03320473 · 29 participants · Start Dec 5, 2017 · Primary completion Jun 20, 2022
Device: IC-8 IOL · For: Cataract; Presbyopia
Sites: Makati City, Philippines
- Post-Approval Study With the KAMRA InlayStatus unknown
AcuFocus, Inc.Not on our public-company list
NCT03173664 · 529 participants (planned) · Start Jul 31, 2018 · Primary completion Jan 2026
Device: KAMRA Inlay · For: Presbyopia
AcuFocus, Inc.Not on our public-company list
NCT00850031 · 119 participants · Start Jan 2009 · Primary completion Oct 2013
Device: AcuFocus Corneal Inlay · For: Presbyopia
Sites: Melbourne, Australia; Bondi Junction, Australia; Salzburg, Austria · 8 sites in all
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Kamra Inlay", and for the whole product code for context.
This brand
9 reports: 0 malfunction, 9 injury, 0 death
Whole product code LQE
297 reports: 34 malfunction, 263 injury, 0 death
Newest reports for this brand
- KAMRA INLAYInjury
3005357288-2019-00005 · Received May 31, 2019 · Event dated Apr 26, 2019
Device type: Implant, Corneal, Refractive (LQE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Abdominal Pain; Corneal Clouding/Hazing
- KAMRA INLAYInjury
3005357288-2019-00002 · Received Apr 5, 2019 · Event dated Mar 8, 2019
Device type: Implant, Corneal, Refractive (LQE)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Foreign Body Sensation in Eye; Patient Problem/Medical Problem
- KAMRA INLAYInjury
3005357288-2019-00003 · Received Apr 5, 2019 · Event dated Mar 14, 2019
Device type: Implant, Corneal, Refractive (LQE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Visual Impairment
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1235-2016 · Started Feb 11, 2016
Reason given: AcuFocus is recalling KAMRA ACI 7000 Corneal Inlays due to concerns with the labeled shelf life.
Cause as FDA categorized it: Under Investigation by firm · Device type: Implant, Corneal, Refractive (LQE)
Published research
The most relevant PubMed records for "Kamra Inlay"[tiab]. The summary above synthesizes these.
- KAMRA presbyopic inlay refractive outcomes: a Canadian perspective.
Darian-Smith E, Gouvea L, Gendler S, et al. · Can J Ophthalmol · 2024
- Explantation of KAMRA Corneal Inlay: 10-Year Occurrence and Visual Outcome Analysis.
Moshirfar M, Lau CK, Chartrand NA, et al. · Clin Ophthalmol · 2022
- Complications of Small Aperture Intracorneal Inlays: A Literature Review.
Sánchez-González MC, Gutiérrez-Sánchez E, Sánchez-González JM, et al. · Life (Basel) · 2023Review
- KAMRA Inlay Implantation for Presbyopia Compensation: A Retrospective Evaluation of Patient Satisfaction and Subjective Vision 12-Month Postoperative.
Harb WG, Chamoun NG, Harb GW · Middle East Afr J Ophthalmol · 2019
- [The KAMRAࡊ inlay : A realistic approach?].
El-Husseiny M, Daas L, Viestenz A, et al. · Ophthalmologe · 2017Clinical Trial
- Clinical utility of the KAMRA corneal inlay.
Naroo SA, Bilkhu PS · Clin Ophthalmol · 2016Review
- Vignetting and field of view with the KAMRA corneal inlay.
Langenbucher A, Goebels S, Szentmáry N, et al. · Biomed Res Int · 2013
- Cataract Surgery in Patients with a Previous History of KAMRA Inlay Implantation: A Case Series.
Moshirfar M, Quist TS, Skanchy DF, et al. · Ophthalmol Ther · 2017
- Effects of femtosecond and excimer lasers on implanted KAMRA corneal inlay in animal models.
Sammouh FK, Baban TA, Dandan WN, et al. · J Fr Ophtalmol · 2017Evaluation Study
- Stereoacuity after small aperture corneal inlay implantation.
Linn SH, Skanchy DF, Quist TS, et al. · Clin Ophthalmol · 2017
- Confocal microscopy evaluation of the corneal response following AcuFocus KAMRA inlay implantation.
Abbouda A, Javaloy J, Alió JL · J Refract Surg · 2014Research Support, Non-U.S. Gov't
- Corneal Inlays for Presbyopia Explanted Due to Corneal Haze.
Ong HS, Chan AS, Yau CW, et al. · J Refract Surg · 2018Case Reports
Other devices of this type
Also filed under product code LQE.
- Intacs Prescription Inserts/Intacs Corneal ImplantsAddition Technology · PMA 2024
- Raindrop® Near Vision InlayRvo 2.0, Inc. (D.B.A. Optics Medical) · PMA 2022
- ReVision Optics Raindrop Near Vision InlayRvo 2.0, Inc. (D.B.A. Optics Medical) · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.